Is whole-body fluorine-18 fluorodeoxyglucose PET/CT plus additional pelvic images (oral hydration-voiding-refilling) useful for detecting recurrent bladder cancer? - Abstract

OBJECTIVE: Because of the urinary excretion of fluorine-18 fluorodeoxyglucose (18F-FDG), FDG-PET or PET/CT is thought of little value in patients with bladder cancer.

The purpose of our study was to investigate the value of 18F-FDG PET/CT with additional pelvic images in detection of recurrent bladder cancers.

METHODS: From December 2006 to August 2010, 35 bladder cancer patients (median age 56 years old, ranging from 35 to 96) underwent routine 18F-FDG PET/CT. To better detect bladder lesions, a new method called as oral hydration-voiding-refilling was introduced, which included that all the patients firstly received oral hydration, then were required to void frequently and finally were demanded to hold back urine when the additional pelvic images were scanned. Lesions were confirmed by either histopathology or clinical follow-up for at least 6 months.

RESULTS:Finally, 12 recurrent cases of 35 patients were confirmed by cystoscope. PET/CT correctly detected 11 of them. Among these 11 true positive patients, 5 patients (45.5 %) were detected only after additional pelvic images. Lichenoid lesions on the bladder wall were missed, which caused 1 false negative result. All three false positive cases were testified to be inflammatory tissues by cystoscope. Therefore, the sensitivity, specificity and accuracy of PET/CT were 91.7 % (11/12), 87.0 % (20/23) and 88.6 % (31/35), respectively.

CONCLUSION: PET/CT with additional pelvic images can highly detect recurrent lesions in residual bladder tissues. Our method with high accuracy and better endurance could be potentially applied.

Written by:
Yang Z, Cheng J, Pan L, Hu S, Xu J, Zhang Y, Wang M, Zhang J, Ye D, Zhang Y.   Are you the author?
Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, No. 270, Dong'an Road, Xuhui, Shanghai, 200032, China.

Reference: Ann Nucl Med. 2012 Jul 5. Epub ahead of print.
doi: 10.1007/s12149-012-0614-3

PubMed Abstract
PMID: 22763630 Bladder Cancer Section